Wolverine Trading, LLC Chembio Diagnostics, Inc. Call Options Transaction History

Wolverine Trading, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$0.2 - $0.33 $280 - $462	-1,400 Reduced 6.45%	20,300 $4,000
Q3 2022 Nov 14, 2022	BUY	$0.35 - $1.1 $7,594 - $23,870	21,700 New	21,700 $9,000
Q2 2022 Aug 15, 2022	SELL	$0.45 - $0.8 $6,165 - $10,960	-13,700 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.66 - $1.23 $13,860 - $25,830	-21,000 Reduced 60.52%	13,700 $12,000
Q3 2021 Nov 12, 2021	BUY	$2.06 - $5.34 $40,788 - $105,732	19,800 Added 132.89%	34,700 $87,000
Q2 2021 Aug 06, 2021	SELL	$2.88 - $5.64 $57,600 - $112,800	-20,000 Reduced 57.31%	14,900 $45,000
Q4 2020 Feb 12, 2021	SELL	$4.11 - $7.51 $32,469 - $59,329	-7,900 Reduced 18.46%	34,900 $170,000
Q3 2020 Nov 13, 2020	BUY	$3.28 - $5.93 $52,808 - $95,473	16,100 Added 60.3%	42,800 $204,000
Q2 2020 Aug 13, 2020	BUY	$3.18 - $15.54 $84,906 - $414,918	26,700 New	26,700 $85,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.